Long-term efficacy, safety and tolerability of secukinumab in children and adolescents with severe chronic plaque psoriasis: Two-year results from a Phase III double-blind, randomized controlled trial

D. Krasowska, T. Gambichler, C. Cortés, A. Horev, N. Compagno, S. S. Dahale, P. Papanastasiou, D. Keefe

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term efficacy, safety and tolerability of secukinumab in children and adolescents with severe chronic plaque psoriasis: Two-year results from a Phase III double-blind, randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences